The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone

Experimental Hematology

Volumn 26, Issue 7, 1998, Pages 597-603

  Grigorieva, I ^a   Thomas, X ^a   Epstein, J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Apoptosis; Drug resistance; Interleukin 6; Multiple myeloma; Stromal cells

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 6;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SELECTION; CORTICOSTEROID THERAPY; CYTOPATHOGENIC EFFECT; DRUG EFFECT; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTIGEN-ANTIBODY REACTIONS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE MARROW CELLS; CELLS, CULTURED; COCULTURE TECHNIQUES; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; HUMANS; MULTIPLE MYELOMA; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 0031781636     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)